Union Conference on Hematology and Blood Transfusion

Oct 23-24, 2019

|

Paris, France

LexisConferences proudly announcing and welcoming the Hematologists from all over the globe to grace your presence at the Union Conference on Hematology and Blood Transfusion during October 23-24, 2019, at world’s favorite locations in Paris, France. Our event is mainly focused on the theme "Transpiring Exploring of Hematology and Blood Transfusions. All the participants are cordially invited to share their research and knowledge to discover new things happening worldwide in the field of Hematology. This forum is expecting participants from all the professionals of Hematology to strengthen and share values for future Hematologists. Our platform will definitely give you the best known around the world and high profile networking opportunities to bag yourself for the future.

Our target audiences are mainly Hematologists, Academicians, Scientists, Hematology Organizations, Hematology Societies and more importantly Nursing students, Ph.D. Graduates and all corporate companies involved in the field of Hematology.

Hematology 2019 features two days of Workshop Scientific Sessions, Keynote talks, Oral and Poster communications, Plenary lectures, and roundtable discussions. This gathering will offer you special prospects to network with Hematologists across the world.

Scientific Sessions:

1. Hematology:

Erythrocytes are also known as red blood cells, which carry oxygen to the body and collect carbon dioxide from the body by the use of and its life span of 120 days. Along the side the leukocytes, help in protecting the healthy cells because the W.B.C active as the defending cells in protecting the immune system from the foreign cells. Formation of blood cellular components is called as Hematopoiesis and all the cellular blood components are derived from stem cells in a healthy individual nearly 1011–1012  new blood cells are produced these help in steady peripheral circulation. If there is an increase of R.B.C in the body these cases these can be measured through a level.

2. Blood Disorders:

The blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of the blood is plasma. The solid part of the blood contains red blood cells, white blood cells and platelets. Blood disorders affect one or more parts of the blood and prevent your blood from doing its work. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in one’s diet.

3: Blood Tests:

A blood test is a laboratory analysis performed on a blood sample that is usually extracted from a vein in the arm using a hypodermic needle, or via finger prick. Multiple tests for specific blood components, such as a glucose test or a cholesterol test, are often grouped together into one test panel called a blood panel or blood work. Blood tests are often used in health care to determine physiological and biochemical states, such as disease, mineral content, pharmaceutical drug effectiveness, and organ function. Typical clinical blood panels include a basic metabolic panel or a complete blood count.

4. Blood Disorders: Treatments:

 Blood disorders can affect any of the three main components of blood- Red blood cells, White blood  cells, Platelets. One must overcome the difficulties with appropriate treatments for them.

5. Pediatric Hematology:

   a branch of Hematology, which deals with child or teen who are suffering from Hematologic Disorders. A pediatric hematologist/oncologist is a specialist who treats children and adolescents with blood diseases or cancer. They are specially trained to work with young patients as well as in both hematology (the study of blood) and oncology (the study of cancer) in children. Pediatric hematologist/oncologists are specially trained to treat children with blood disorders and cancer, some of which appear exclusively in the early years of life. Children are not little adults, and they should receive medical care from a physician who understands the developmental stages the human body as well as how interact with young patients. In addition, hematologists/oncologists have formal training to treat childhood forms of blood disorders and cancer. Not only do children have different blood disorders and cancers than children also tolerate treatments differently than adults.

6. Immunology with Hematology: 

Elucidation of the various cell types in blood (neutrophils, macrophages, T-cells, B-cells, erythrocytes, platelets) and their specific role in normal blood function and host defense has transformed medicine and our ability to treat human disease. Blood groups  are of ABO type and but at present the Rh blood grouping of 50 well defined  antigens in which 5 are more important they are DCE  and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of lacking of Rh antigen it defined as negative and  of in blood leads to positive these leads to Rh incompatibility. The prevention, treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer too. The disorder of leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the of an abnormal immune response to the body or an immune suppression is known as an Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition, mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

7. Blood Donations/Blood Banking & Tests:

 Blood banking is the process that takes place in the lab to make sure that donated blood, or blood products, is safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases.

8. Hematology Nursing: 

Hematology nurses are specially trained to provide nursing care for patients with blood diseases or disorders. They may also assist with blood transfusions, blood tests, research, and chemotherapy. If you go into hematology, expect to have more responsibility than other nurses, prescriptive authority, and the ability to order diagnostic lab work. Some of the more commonly-known blood diseases and disorders a Hematology nurse may encounter include: Leukemia, lymphoma, sickle cell anemia and hemophilia. Hematology nurses initiate a plan of care to manage symptoms that result from such blood problems. Hematology nursing is often closely associated with oncology nursing, and some nurses will help patients with pain management if their cancer is particularly aggressive. Hematology nurses may work with adults only or specialize in working only with children i.e. Pediatric Hematology nurses. Their responsibilities include: taking medical histories, performing examinations, starting IVs and working with physicians to diagnose various blood diseases and disorders. Hematology nurses also educate patients and their families on how to live with and manage their blood disease. They may also assist with blood transfusions, blood tests, research and chemotherapy. Advanced practice Hematology nursing has some prescriptive authority and can also order diagnostic lab work done.

9. Veterinary Hematology:

Decisions to request Hematology tests in animals are largely based on the cost of the test versus the potential benefit of the result of the animal. A CBC is routinely done to establish a database for patient evaluation, while other Hematology tests may be done in an attempt to evaluate a specific problem. Examples of more specific hematologic tests that focus on a problem identified during the diagnostic evaluation of an animal include coagulation tests, such as prothrombin time; bone marrow biopsy and interpretation; and immunologic tests, such as the direct Coombs’ test.

10.   Based Products:

 A blood substitute is a substance used to mimic and fulfil some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Thus far, there are no -accepted oxygen-carrying blood substitutes, which are the typical objective of a red blood cell transfusion; however, there are widely available non-blood volume expanders for cases where only volume restoration is required. These are helping doctors and surgeons avoid the risks of disease transmission and immune suppression, address the chronic blood donor shortage, and address the concerns of Jehovah's Witnesses and others who have religious objections to receiving transfused blood. Pathogen reduction using riboflavin and UV light is a method by which infectious pathogens in blood for transfusion are inactivated by adding riboflavin and irradiating with UV light. This method reduces the infectious levels of disease-causing agents that may be found in blood components, while still maintaining good quality blood components for transfusion. This type of approach to increase blood safety is also known as “pathogen inactivation” in the industry. An artificial cell or minimal cell is an engineered particle that mimics one or many functions of a biological cell. The term does not refer to a specific physical entity, but rather to the idea that certain functions or structures of biological cells can be replaced or supplemented with a synthetic entity. Often, artificial cells are biological or polymeric membranes, which enclose biologically active materials. As such, nanoparticles, liposomes and a number of other particles have qualified as artificial cells. Manufacturing of semi synthetic products of drugs is known as therapeutic biological products. Anticoagulants () are a class of drugs that work to prevent the coagulation (clotting) of blood. Such substances occur naturally in leeches and insects.

11.Transfusion Medicine and Hematology Research:

 Lymphatic diseases this is a type of cancer of the lymphatic system. It can start almost anywhere in the body. It's believed to be caused by HIV, Epstein-Barr Syndrome, age and family history. Symptoms include weight loss, fever, swollen lymph nodes, night sweats, itchy skin, fatigue, chest pain, coughing and/or trouble swallowing. The lymphatic system is part of the circulatory system, comprising a network of lymphatic vessels that carry a clear fluid called lymph directionally towards the heart. The lymphatic system was first described in the seventeenth century independently by Olaus Rudbeck and Thomas Bartholin. Unlike the cardiovascular system, the lymphatic system is not a closed system. The human circulatory system processes an average of 20 of blood per day through capillary filtration, which removes plasma while leaving the blood cells. Roughly 17 of the filtered plasma get reabsorbed directly into the blood vessels, while the remaining 3 are left behind in the interstitial fluid. One of the main functions of the lymph system is to provide an accessory return route to the blood for the surplus 3 Lymphatic diseases are of Non-Hodgkin's Lymphoma, Hodgkins. The thymus is a specialized primary lymphoid organ of the immune system. Within the thymus, T cells or T lymphocytes mature. T cells are critical to the adaptive immune system, where the body adapts specifically to foreign invaders. One of the examples of lymph node development. Formation of lymph node into the tumor, which leads to cancer called oncology.

12. New Drug Discovery in Hematology:

 Advancing novel therapeutic agents for the treatment of malignancy in the marketplace is an increasingly costly and lengthy process. As such, new strategies for drug discovery are needed. Drug represents an opportunity to rapidly advance new therapeutic strategies into clinical trials at a relatively low cost. Known on-patent or off-patent drugs with unrecognized anticancer activity can be rapidly advanced into clinical testing for this new indication by leveraging their known pharmacology, pharmacokinetics, and toxicology. Using this approach, academic groups can participate in the drug discovery field and smaller biotechnology companies can “de-risk” early-stage drug discovery projects.

On behalf of LexisConferencesConferences, Paris is greeting you warmly for this prestigious Hematology 2019 Forum

Join us and write us your queries at [email protected]

   WhatsApp Chat Service – 24×7: +1 (213) 328-1869

 

 

Program Overview

Our Collaborations, Sponsors, Media Partners